Wednesday, June 17, 2026

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Antimony Resources Drills 5.45% Antimony Over 10.3 Metres At Bald Hill

PTX Metals Hits 92% Copper Recovery in Debut W2 Testwork

Related News

Trump Signs Order to Move Cannabis to Schedule III

President Donald Trump signed an executive order Thursday to push marijuana from Schedule I toward...

Friday, December 19, 2025, 03:02:00 PM

‘Big Success’: Trump Secures NATO Agreement to More Than Double Defense Spending

NATO allies agreed this week to dramatically increase defense spending to 5% of their gross...

Thursday, June 26, 2025, 12:54:00 PM

India Faces Steeper US Tariffs… If Russia Won’t Agree To Peace Talks?

While not part of Friday’s Alaska summit, India is facing it with a clear downside:...

Friday, August 15, 2025, 11:14:00 AM

Behind Trump’s Pledge To Never, Ever Ride A Bicycle After Biden Fall

In case anyone was concerned, former President Donald Trump has pledged to never, ever ride...

Thursday, June 23, 2022, 10:14:00 AM

British Columbia’s Eby Also Plans Anti-Tariff US Ads After Ford Drew Trump’s Ire

While Ontario Premier Doug Ford drew the ire of President Donald Trump on his Reagan...

Monday, October 27, 2025, 02:18:00 PM